ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2141

Terminal Uridylyl Transferase ZCCHC6-Dependent Generation of miRNA Diversity in Primary Human Chondrocytes

Abdul Haseeb1, Mohammad Shahidul Makki2, Mohammad Ansari3, Helen Piontkivska4 and Tariq M. Haqqi1, 1Anatomy & Neurobiology, Northeast Ohio Medical University, Rootstown, OH, 24209 St Rt 44 PO Box 95, Northeast Ohio Medical University, Rootstown, OH, 3Anatomy & Neurobiology, Northeast Ohio Medical University, Roostown, OH, 4Kent State University, Kent, OH

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: chondrocytes and osteoarthritis, MicroRNA

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Biology and Pathology of Bone and Joint - Poster I

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Terminal Uridylyl Transferase ZCCHC6-dependent Generation Of miRNA Diversity In Primary Human Chondrocytes

Background/Purpose: MicroRNAs (miRNAs) are a group of small, noncoding RNAs that post-transcriptionally regulate gene expression. miRNAs play important roles in chondrocyte function and in the development of osteoarthritis. We characterized the dynamic repertoire of the chondrocyte miRNAs and isomiRs by deep sequencing analysis in chondrocytes isolated from normal subjects as well as OA patients in response to the treatment with inflammatory cytokine IL-1b. We also tested the role of TUT7/ZCCHC6 in non-template addition of nucleotides at the ends of specific miRNAs in human chondrocytes.

Methods: Joint cartilage samples were obtained from normal subjects at autopsy and OA patients who underwent joint arthroplasty at the Crystal Clinic, Akron, OH. Primary human chondrocytes were prepared by sequential digestion of the cartilage pieces by pronase (1 mg/ml) for 2 hrs and collagenase A (1 mg/ml) for 16 hrs. Cells were serum starved overnight followed by treatment with IL-1b (2 ng/ml) for different durations (2 hrs, 12 hrs and 24 hrs). Expression of TUT7/ZCCHC6 was knocked down using ON-TARGETplus SMARTpool (GE Dharmacon). Total RNA was prepared using miRNeasy kit (Qiagen) and libraries for sequencing were prepared using True seq small RNA library preparation kit (Illumina). Next generation sequencing was performed on Illumina MiSeq sequencer. Data were analyzed using CLC genomics suite version 8 (Qiagen).

Results: There was a modest difference in the expression of miRNAs in normal and OA chondrocytes in the presence or absence of IL-1b. We found a number of miRNAs that showed a wide range of sequence modifications including nucleotide additions and deletions at 5’ and 3’ ends; and nucleotide substitutions. Some modifications resulted in seed shifts. Interestingly, miR-140-3p, an important miRNA involved in chondrocyte function, was found to have the highest number of modifications (Figure 1). Many of these modifications have been shown to impart a change in the miRNAs’ ability to regulate gene expression. Knockdown of TUT7/ZCCHC6 resulted in a significant change in the isomiR profile in human chondrocytes demonstrating that TUT7/ZCCHC6 contributes to the miRNA complexity in human chondrocytes.

Conclusion: Together, these results reveal a complex repertoire of miRNAs and isomiRs in primary human chondrocytes and their dynamic changes in response to IL-1b treatment. Here we also show the role of TUT7/ZCCHC6 in generating the miRNA diversity in human chondrocytes. These findings will help us better understand miRNA-mediated control of gene expression in the pathogenesis of OA.  This work was supported in part by USPHS/NIH grants (RO1 AT007373, RO1 AT005520, RO1 AR067056, R21 AR064890) and funds from North East Ohio Medical University to TMH. 

Figure 1. A. Number of modifications in 10 most modified miRNAs with ³100 reads. B. Individual modifications with ³100 read counts in miR-140-3p aligned with the archetype miRBase sequence.


Disclosure: A. Haseeb, None; M. Shahidul Makki, None; M. Ansari, None; H. Piontkivska, None; T. M. Haqqi, None.

To cite this abstract in AMA style:

Haseeb A, Shahidul Makki M, Ansari M, Piontkivska H, Haqqi TM. Terminal Uridylyl Transferase ZCCHC6-Dependent Generation of miRNA Diversity in Primary Human Chondrocytes [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/terminal-uridylyl-transferase-zcchc6-dependent-generation-of-mirna-diversity-in-primary-human-chondrocytes/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/terminal-uridylyl-transferase-zcchc6-dependent-generation-of-mirna-diversity-in-primary-human-chondrocytes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology